Data completeness
0/8 — Limited
Drug data last refreshed 19h ago · AI intelligence enriched 1w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
NEOSPORIN is a topical cream formulation indicated for chronic wound management, leveraging the established antibiotic/antiseptic combination brand for dermatological use. The product is a small-molecule topical cream in pre-launch stage under GSK sponsorship.
Pre-Launch
Pre-launch stage indicates small but growing team focused on launch readiness; commercial expansion expected post-approval.
Mechanism of Action
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Career Relevance
Joining the NEOSPORIN chronic wound team during pre-launch offers early-stage career opportunity to build a product from regulatory approval through commercial launch. Roles span regulatory, clinical, and commercial functions with growth potential tied to product approval and market penetration.
Brand ManagerProduct Manager
Worked on NEOSPORIN at GSK? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.